Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,407 · see citing works

Improved protein–ligand docking using GOLD

Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W., & Taylor, R. D. (2003) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10465 · Cited by 3,073 · see citing works

Advances in methods and algorithms in a modern quantum chemistry program package

Shao, Y., Füsti-Molnár, L., Jung, Y., Kußmann, J., Ochsenfeld, C., Brown, S. T., Gilbert, A. T. B., Slipchenko, L. V., Levchenko, S. V., O'Neill, D. P., et al. (2006) · Physical Chemistry Chemical Physics · doi:10.1039/b517914a · Cited by 2,805 · see citing works

Ligand efficiency: a useful metric for lead selection

Hopkins, A. L., Groom, C. R., & Alex, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03069-7 · Cited by 1,895 · see citing works

IAP proteins: blocking the road to death's door

Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756 · see citing works

Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation

Jones, G., Willett, P., & Glen, R. C. (1995) · Journal of Molecular Biology · doi:10.1016/s0022-2836(95)80037-9 · Cited by 1,548 · see citing works

TNF-α Induces Two Distinct Caspase-8 Activation Pathways

Wang, L., Du, F., & Wang, X. (2008) · Cell · doi:10.1016/j.cell.2008.03.036 · Cited by 1,352 · see citing works

Structural basis of IAP recognition by Smac/DIABLO

Wu, G., Chai, J., Suber, T. L., Wu, J., Du, C., Wang, X., & Shi, Y. (2000) · Nature · doi:10.1038/35050012 · Cited by 863 · see citing works

Targeting IAP proteins for therapeutic intervention in cancer

Fulda, S., & Vucic, D. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3627 · Cited by 837 · see citing works

The rise of fragment-based drug discovery

Murray, C. W., & Rees, D. C. (2009) · Nature Chemistry · doi:10.1038/nchem.217 · Cited by 803 · see citing works

Structural Basis for the Inhibition of Caspase-3 by XIAP

Riedl, S. J., Renatus, M., Schwarzenbacher, R., Zhou, Q., Sun, C. C., Fesik, S. W., Liddington, R., & Salvesen, G. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00274-4 · Cited by 793 · see citing works

IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer

Gyrd-Hansen, M., & Meier, P. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2889 · Cited by 790 · see citing works

Mechanism of XIAP-Mediated Inhibition of Caspase-9

Shiozaki, E. N., Chai, J., Rigotti, D. J., Riedl, S. J., Li, P., Srinivasula, S. M., Alnemri, E. S., Fairman, R., & Shi, Y. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00054-6 · Cited by 718 · see citing works

Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain

Liu, Z., Sun, C. C., Olejniczak, E. T., Meadows, R. P., Betz, S. F., Oost, T. K., Herrmann, J. E., Wu, J. C., & Fesik, S. W. (2000) · Nature · doi:10.1038/35050006 · Cited by 647 · see citing works

Structural Basis of Caspase-7 Inhibition by XIAP

Chai, J., Shiozaki, E. N., Srinivasula, S. M., Wu, Q. Y., Dataa, P., Alnemri, E. S., & Shi, Y. (2001) · Cell · doi:10.1016/s0092-8674(01)00272-0 · Cited by 582 · see citing works

Autocrine TNFα Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced Apoptosis

Petersen, S. L., Wang, L., Yalcin-Chin, A., Li, L., Peyton, M., Minna, J. D., Harran, P. G., & Wang, X. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.029 · Cited by 572 · see citing works

c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB Activation

Varfolomeev, E. E., Goncharov, T., Fedorova, A. V., Dynek, J. N., Zobel, K., Deshayes, K., Fairbrother, W. J., & Vucic, D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800128200 · Cited by 554 · see citing works

Fragment-Based Approaches in Drug Discovery and Chemical Biology

Scott, D. E., Coyne, A. G., Hudson, S. A., & Abell, C. (2012) · Biochemistry · doi:10.1021/bi3005126 · Cited by 460 · see citing works

Fragment-Based Lead Discovery Using X-ray Crystallography

Hartshorn, M. J., Murray, C. W., Cleasby, A., Frederickson, M., Tickle, I. J., & Jhoti, H. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0495778 · Cited by 425 · see citing works

XIAP inhibits caspase‐3 and ‐7 using two binding sites: evolutionarily conserved mechanism of IAPs

Scott, F. L., Denault, J., Riedl, S. J., Shin, H., Renatus, M., & Salvesen, G. S. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600544 · Cited by 420 · see citing works

Molecular Field Extrema as Descriptors of Biological Activity: Definition and Validation

Cheeseright, T., Mackey, M. D., Rose, S., & Vinter, A. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050357s · Cited by 409 · see citing works

An exegesis of IAPs: salvation and surprises from BIR motifs

Miller, L. K. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01609-8 · Cited by 370 · see citing works

Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer

Oost, T. K., Sun, C. C., Armstrong, R. C., Al-Assaad, A.-S., Betz, S. F., Deckwerth, T. L., Ding, H., Elmore, S. W., Meadows, R. P., Olejniczak, E. T., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040037k · Cited by 367 · see citing works

Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs.

Verhagen, A. M., Coulson, E. J., & Vaux, D. L. (2001) · Genome biology · doi:10.1186/gb-2001-2-7-reviews3009 · Cited by 363 · see citing works

A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity

Nociari, M., Shalev, A., Benias, P. C., & Russo, C. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00028-3 · Cited by 351 · see citing works

Electrostatic Control of Aromatic Stacking Interactions

Cockroft, S. L., Hunter, C. A., Lawson, K. R., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja050880n · Cited by 336 · see citing works

Inhibitor of Apoptosis (IAP) Proteins-Modulators of Cell Death and InflammationPreprint

Silke, J., & Meier, P. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008730 · Cited by 329 · see citing works

A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment

Cai, Q., Sun, H., Peng, Y., Lü, J., Nikolovska‐Coleska, Z., McEachern, D., Liu, L., Qiu, S., Yang, C., Miller, R. S., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101505d · Cited by 274 · see citing works

Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)

Flygare, J. A., Beresini, M., Budha, N., Chan, H., Chan, I. T., Cheeti, S., Cohen, F., Deshayes, K., Doerner, K., Eckhardt, S. G., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300060k · Cited by 252 · see citing works

Constructing and decoding unconventional ubiquitin chains

Behrends, C., & Harper, J. W. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2066 · Cited by 223 · see citing works

Smac/DIABLO Selectively Reduces the Levels of c-IAP1 and c-IAP2 but Not That of XIAP and Livin in HeLa Cells

Yang, Q.-H., & Du, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401253200 · Cited by 213 · see citing works

High Expression Levels of X-Linked Inhibitor of Apoptosis Protein and Survivin Correlate with Poor Overall Survival in Childhood de Novo Acute Myeloid Leukemia

Tamm, I., Richter, S., Oltersdorf, D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0642 · Cited by 166 · see citing works

Birinapant, a Smac-Mimetic with Improved Tolerability for the Treatment of Solid Tumors and Hematological Malignancies

Condon, S. M., Mitsuuchi, Y., Deng, Y., LaPorte, M. G., Rippin, S. R., Haimowitz, T., Alexander, M. D., Kumar, P. T., Hendi, M. S., Lee, Y.-H., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500176w · Cited by 153 · see citing works

Extended electron distributions applied to the molecular mechanics of some intermolecular interactions

Vinter, J. G. (1994) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124013 · Cited by 129 · see citing works

Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis

Mizutani, Y., Nakanishi, H., Li, Y. Z., Matsubara, H., Yamamoto, K., Sato, N., Shiraishi, T., Nakamura, T., Mikami, K., Okihara, K., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.4.919 · Cited by 129 · see citing works

(Un)expected roles of c-IAPs in apoptotic and NFκB signaling pathways

Varfolomeev, E. E., & Vucic, D. (2008) · Cell Cycle · doi:10.4161/cc.7.11.5959 · Cited by 125 · see citing works

Using a Fragment‐Based Approach To Target Protein–Protein Interactions

Scott, D. E., Ehebauer, M. T., Pukala, T. L., Marsh, M., Blundell, T. L., Venkitaraman, A. R., Abell, C., & Hyvönen, M. (2013) · ChemBioChem · doi:10.1002/cbic.201200521 · Cited by 123 · see citing works

Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582)

Hennessy, E. J., Adam, A., Aquila, B. M., Castriotta, L., Cook, D. J., Hattersley, M. M., Hird, A. W., Huntington, C., Kamhi, V. M., Laing, N. M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401075x · Cited by 118 · see citing works

Assessing the lipophilicity of fragments and early hits

Mortenson, P. N., & Murray, C. W. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9435-z · Cited by 112 · see citing works

Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function

Saalau-Bethell, S., Woodhead, A., Chessari, G., Carr, M., Coyle, J., Graham, B., Hiscock, S., Murray, C., Pathuri, P., Rich, S., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1081 · Cited by 109 · see citing works

Antagonism of c-IAP and XIAP Proteins Is Required for Efficient Induction of Cell Death by Small-Molecule IAP Antagonists

Ndubaku, C. O., Varfolomeev, E. E., Wang, L., Zobel, K., Lau, K., Elliott, L. O., Maurer, B., Fedorova, A. V., Dynek, J. N., Koehler, M. F. T., et al. (2009) · ACS Chemical Biology · doi:10.1021/cb900083m · Cited by 102 · see citing works

Group Efficiency: A Guideline for Hits‐to‐Leads Chemistry

Verdonk, M. L., & Rees, D. C. (2008) · ChemMedChem · doi:10.1002/cmdc.200800132 · Cited by 85 · see citing works

Development of Peptidomimetics Targeting IAPs

SHARMA, S. K., Straub, C. S., & Zawel, L. S. (2006) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-005-9003-2 · Cited by 61 · see citing works

Non-peptidic small molecule inhibitors of XIAP

Park, C., Sun, C. C., Olejniczak, E. T., Wilson, A. E., Meadows, R. P., Betz, S. F., Elmore, S. W., & Fesik, S. W. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.11.010 · Cited by 56 · see citing works

Learning and Confirming with Preclinical Studies: Modeling and Simulation in the Discovery of GDC-0917, an Inhibitor of Apoptosis Proteins Antagonist

Wong, H., Gould, S. E., Budha, N. R., Darbonne, W. C., Kadel, E. E., La, H., Alicke, B., Halladay, J. S., Erickson, R., Portera, C. C., et al. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.053926 · Cited by 54 · see citing works

Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain

Kester, R. F., Donnell, A. F., Lou, Y., Remiszewski, S., Lombardo, L. J., Chen, S., Le, N. T., Lo, J. C. Y., Moliterni, J., Han, X., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400732v · Cited by 39 · see citing works

Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy

Seneci, P., Bianchi, A., Battaglia, C., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.07.009 · Cited by 39 · see citing works

Design and Synthesis of Potent Inhibitor of Apoptosis (IAP) Proteins Antagonists Bearing an Octahydropyrrolo[1,2-a]pyrazine Scaffold as a Novel Proline Mimetic

Hashimoto, K., Saito, B., Miyamoto, N., Oguro, Y., Tomita, D., Shiokawa, Z., Asano, M., Kakei, H., Taya, N., Kawasaki, M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301674z · Cited by 33 · see citing works

A web-based platform for virtual screening

Watson, P., Verdonk, M. L., & Hartshorn, M. J. (2003) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(03)00137-2 · Cited by 27 · see citing works

Determination of the Sequence Specificity of XIAP BIR Domains by Screening a Combinatorial Peptide Library

Sweeney, M. C., Wang, X., Park, J., et al. (2006) · Biochemistry · doi:10.1021/bi061782x · Cited by 24 · see citing works

Time‐Dependent Inhibition and Induction of Human Cytochrome P4503A4/5 by an Oral IAP Antagonist, LCL161, In Vitro and In Vivo in Healthy Subjects

Dhuria, S. V., Einolf, H. J., Mangold, J. B., Sen, S., Gu, H., Wang, L., & Cameron, S. B. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.79 · Cited by 23 · see citing works

Internal motions prime cIAP1 for rapid activation

Phillips, A. H., Schoeffler, A. J., Matsui, T., Weiss, T. M., Blankenship, J. W., Zobel, K., Giannetti, A. M., Dueber, E. C., & Fairbrother, W. J. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2916 · Cited by 19 · see citing works

Structural and Biophysical Characterization of XIAP BIR3 G306E Mutant: Insights in Protein Dynamics and Application for Fragment‐Based Drug Design

Moore, C. D., Wu, H., Bolaños, B., et al. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00862.x · Cited by 17 · see citing works

NMR Study to Identify a Ligand-Binding Pocket in Ras

Maurer, T., & Wang, W. (2013) · The Enzymes · doi:10.1016/b978-0-12-416749-0.00002-6 · Cited by 9 · see citing works

Targeted protein degradation: expanding the toolbox

Schapira, M., Calabrese, M. F., Bullock, A. N., & Crews, C. M. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0047-y · Cited by 960 · see citing works

Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery

Davies, T. G., Wixted, W. E., Coyle, J. E., Griffiths-Jones, C., Hearn, K., McMenamin, R., Norton, D., Rich, S. J., Richardson, C., Saxty, G., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00228 · Cited by 322 · see citing works

Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation

Maniaci, C., Hughes, S. J., Testa, A., Chen, W., Lamont, D. J., Rocha, S., Alessi, D. R., Romeo, R., & Ciulli, A. (2017) · Nature Communications · doi:10.1038/s41467-017-00954-1 · Cited by 245 · see citing works

Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexes

Schiemer, J., Horst, R., Meng, Y., Montgomery, J. I., Xu, Y., Feng, X., Borzilleri, K., Uccello, D. P., Leverett, C., Brown, S., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-020-00686-2 · Cited by 113 · see citing works

Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)

Tamanini, E., Buck, I. M., Chessari, G., Chiarparin, E., Day, J. E. H., Frederickson, M., Griffiths-Jones, C. M., Hearn, K., Heightman, T. D., Iqbal, A., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01877 · Cited by 72 · see citing works

Therapeutics Targeting the Core Apoptotic Machinery

Hamilton, C., Fox, J. P., Longley, D. B., & Higgins, C. A. (2021) · Cancers · doi:10.3390/cancers13112618 · Cited by 26 · see citing works

Faculty Opinions recommendation of Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP).

Congreve, M., & Pickworth, M. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727604992.793532954

Influence of caspase-binding ability of the X-linked Inhibitor of Apoptosis Protein (XIAP) on serine protease inhibitor-sensitive apoptosis

Walliser, M. (2005)

Apoptotic sensitivity of murine IAP-deficient cells

Rumble, J. M., Bertrand, M. J. M., Csomos, R. A., Wright, C. W., Albert, L., Mak, T. W., Barker, P. A., & Duckett, C. S. (2008) · Biochemical Journal · doi:10.1042/bj20081188 · Cited by 19 · see citing works

IκB Kinase ε-Dependent Phosphorylation and Degradation of X-Linked Inhibitor of Apoptosis Sensitizes Cells to Virus-Induced Apoptosis

Nakhaei, P., Sun, Q., Solis, M., Mésplède, T., Bonneil, É., Paz, S., Lin, R., & Hiscott, J. B. (2011) · Journal of Virology · doi:10.1128/jvi.05989-11 · Cited by 32 · see citing works

Inhibitor of Apoptosis ( IAP ) and BIR ‐containing Proteins

Vaux, D. L. (2009) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0021570